Difference between revisions of "Team:Hong Kong UCCKE/Parts"

Line 72: Line 72:
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197300">2197300</a></td>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197300">2197300</a></td>
 
     <td>Expression of GFP under the control of a uric acid concentration-sensitive promoter device</td>
 
     <td>Expression of GFP under the control of a uric acid concentration-sensitive promoter device</td>
     <td>1890</td>
+
     <td>1924</td>
 
   </tr>
 
   </tr>
 
   <tr>
 
   <tr>
Line 82: Line 82:
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197400">2197400</a></td>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197400">2197400</a></td>
 
     <td>Expression of smUOX under the control of a uric acid concentration-sensitive promoter device</td>
 
     <td>Expression of smUOX under the control of a uric acid concentration-sensitive promoter device</td>
     <td>2139</td>
+
     <td>2119</td>
 
   </tr>
 
   </tr>
 
   <tr>
 
   <tr>
Line 92: Line 92:
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197500">2197500</a></td>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197500">2197500</a></td>
 
     <td>Expression of YgFU under the control of a constitutive promoter</td>
 
     <td>Expression of YgFU under the control of a constitutive promoter</td>
     <td>1625</td>
+
     <td>1647</td>
 
   </tr>
 
   </tr>
 
   <tr>
 
   <tr>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197502">2197502</a></td>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197502">2197502</a></td>
 
     <td>Expression of YgFU under the control of a uric acid concentration-sensitive promoter device</td>
 
     <td>Expression of YgFU under the control of a uric acid concentration-sensitive promoter device</td>
     <td>2652</td>
+
     <td>2653</td>
 
   </tr>
 
   </tr>
 
   <tr>
 
   <tr>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197510">2197510</a></td>
 
     <td><a href="http://parts.igem.org/Part:BBa_K2197510">2197510</a></td>
 
     <td>Expression of GLUT9 under the control of a constitutive promoter</td>
 
     <td>Expression of GLUT9 under the control of a constitutive promoter</td>
     <td>2026</td>
+
     <td>2061</td>
 
   </tr>
 
   </tr>
 
   <tr>
 
   <tr>

Revision as of 13:23, 13 October 2017

Basic Parts

Clicking on the part ID leads to the part page.

Part ID Type Short Description Length
2197302 Protein domain KRAB amplifies the repression effect of HucR repressor. Resulting repressor is chimeric mammalian urate-dependent transsilencer (mUTS). 915
2197303 Regulatory Repressor operator site for mammalian urate-dependent transsilencer (mUTS). 32
2197402 Protein domain Mammalian version of urate oxidase (UOX) 969
2197501 Protein domain E.coli-originated uric acid transporter that absorbs surrounding uric acid into the cell and allow the urate oxidase to catalyse uric acid into allantoin. 1449
2197511 Protein domain Uric acid and glucose transporter Glut 9b 1885

Composite Parts

Clicking on the part ID leads to the part page.

Part ID Short Description Length
2197300 Expression of GFP under the control of a uric acid concentration-sensitive promoter device 1924
2197301 GFP downstream a repressor operator site 833
2197400 Expression of smUOX under the control of a uric acid concentration-sensitive promoter device 2119
2197401 smUOX downstream a repressor operator site 1082
2197500 Expression of YgFU under the control of a constitutive promoter 1647
2197502 Expression of YgFU under the control of a uric acid concentration-sensitive promoter device 2653
2197510 Expression of GLUT9 under the control of a constitutive promoter 2061
2197600 Expression of Aprotinin under the control of a constitutive promoter 1544

<groupparts>iGEM17 Hong_Kong_UCCKE</groupparts>